Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus^®-Poloxamer 188

References

• Alexeev M, Grosenbaugh DK, Mott DD, Fisher JL. (2012). The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors. Neuropharmacology 62:2507–14.
   PubMed Web of Science ®Google Scholar
• Alqahtani MS, Islam MS, Podaralla S, et al. (2017). Food protein based core-shell nanocarriers for oral drug delivery: effect of shell composition on in vitro and in vivo functional performance of zein nanocarriers. Mol Pharm 14:757–69.
   PubMed Web of Science ®Google Scholar
• Andrade F, das Neves J, Gener P, et al. (2015). Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin. Nanomedicine 11:1621–31.
   PubMed Web of Science ®Google Scholar
• Bi C, Miao X, Chow S, et al. (2017). Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. Nanomedicine 13:943–53.
   PubMed Web of Science ®Google Scholar
• Chen LC, Liu YC, Liang YC, et al. (2009). Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J Agric Food Chem 57:7331–7.
   PubMed Web of Science ®Google Scholar
• Chen YH, Huang PH, Lin FY, et al. (2011). Magnolol: a multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis. Eur J Integr Med 3:e317–24.
   Web of Science ®Google Scholar
• Deng J, Huang L, Liu F. (2010). Understanding the structure and stability of paclitaxel nanocrystals. Int J Pharm 390:242–9.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang Z, Liu C, et al. (2015). The studies of N-octyl-N-arginine-chitosan coated liposome as an oral delivery system of cyclosporine A. J Pharm Pharmacol 67:1363–70.
   PubMed Web of Science ®Google Scholar
• Dian L, Yu E, Chen X, et al. (2014). Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett 9:2406.
   PubMed Web of Science ®Google Scholar
• Fares AR, Elmeshad AN, Kassem M. (2018). Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study. Drug Deliv 25:132–42.
   PubMed Web of Science ®Google Scholar
• Fu Y, Liu B, Zhang N, et al. (2013). Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways. J Ethnopharmacol 145:193–9.
   PubMed Web of Science ®Google Scholar
• Han M, Yu X, Guo Y, et al. (2014). Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. Coll Surf B Biointerf 116:114–20.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Amini M, Sohrabi M, et al. (2019). Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization. Int J Pharm 562:124–34.
   PubMed Web of Science ®Google Scholar
• Hu XY, Lou H, Hageman MJ. (2018). Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. Int J Pharm 552:154–63.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang Y, Zhang Z, et al. (2016). Juglone loaded Poloxamer 188/phospholipid mixed micelles evaluated in vitro and in vivo in breast cancer. Int J Pharm 515:359–66.
   PubMed Web of Science ®Google Scholar
• Kimura O, Fujii Y, Haraguchi K, et al. (2016). Effect of quercetin on the uptake and efflux of aristolochic acid I from Caco-2 cell monolayers. J Pharm Pharmacol 68:883–9.
   PubMed Web of Science ®Google Scholar
• Lee CW, Hu SC, Yen FL, et al. (2017). Magnolol nanoparticles exhibit improved water solubility and suppress TNF-α-induced VCAM-1 expression in endothelial cells. J Biomed Nanotechnol 13:255–68.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JJ, Park JH, et al. (2016). Electrosprayed nanocomposites based on hyaluronic acid derivative and Soluplus for tumor-targeted drug delivery. Coll Surf B Biointerf 145:267–74.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang J, Fang Y, et al. (2020). Enhancing betulinic acid dissolution rate and improving antitumor activity via nanosuspension constructed by anti-solvent technique. Drug Des Devel Ther 14:243–56.
   PubMed Web of Science ®Google Scholar
• Liang WZ, Chou CT, Chang HT, et al. (2014). The mechanism of honokiol-induced intracellular Ca(2+) rises and apoptosis in human glioblastoma cells. Chem Biol Interact 221:13–23.
   PubMed Web of Science ®Google Scholar
• Linn M, Collnot EM, Djuric D, et al. (2012). Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci 45:336–43.
   PubMed Web of Science ®Google Scholar
• Lu X, Lu X, Zhang Z, Lv H. (2020). Preparation and characterization of honokiol nanosuspensions and preliminary evaluation of anti-inflammatory effect. AAPS PharmSciTech 1021:62.
   Web of Science ®Google Scholar
• Ma Y, He H, Xia F, et al. (2017). In vivo fate of lipid-silybin conjugate nanoparticles: implications on enhanced oral bioavailability. Nanomedicine 13:2643–54.
   PubMed Web of Science ®Google Scholar
• Mandal A, Bisht R, Rupenthal ID, Mitra AK. (2017). Polymeric micelles for ocular drug delivery: from structural frameworks to recent preclinical studies. J Control Release 248:96–116.
   PubMed Web of Science ®Google Scholar
• Mathot F, des Rieux A, Ariën A, et al. (2007). Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier. J Control Release 124:134–43.
   PubMed Web of Science ®Google Scholar
• Medarević DP, Kleinebudde P, Djuriš J, et al. (2016). Combined application of mixture experimental design and artificial neural networks in the solid dispersion development. Drug Dev Ind Pharm 42:389–402.
   PubMed Web of Science ®Google Scholar
• Mori D, Makwana J, Parmar R, et al. (2016). Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement. Pak J Pharm Sci 29:1927–36.
   PubMed Web of Science ®Google Scholar
• Na YG, Pham TMA, Byeon JJ, et al. (2020). Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor. Int J Pharm 581:119287.
   PubMed Web of Science ®Google Scholar
• Nagaraj K, Narendar D, Kishan V. (2017). Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability. Drug Dev Ind Pharm 43:1186–96.
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Rueda J, Wang Z, Betageri GV. (2016). Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine. Int J Pharm 505:79–88.
   PubMed Web of Science ®Google Scholar
• Shen H, Liu S, Ding P, et al. (2018). Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61. J Pharm Pharmacol 70:498–506.
   PubMed Web of Science ®Google Scholar
• Sandhu PS, Kumar R, Katare OP, et al. (2017). Surface-tailored nanomixed micelles containing quercetin-salicylic acid physical complex for enhanced cellular and in vivo activities: a quality by design perspective. Nanomedicine 12:1281–303.
   PubMed Web of Science ®Google Scholar
• Tang L, Zhu Z, Xie M, et al. (2019). Effects of β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Inclusions on the Degradation of Magnolol by Intestinal Bacteria. AAPS PharmSciTech 20:244.
   PubMed Web of Science ®Google Scholar
• Tsai JJ, Chen JH, Chen CH, et al. (2020). Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo. Environ Toxicol 35:167–75.
   PubMed Web of Science ®Google Scholar
• Tsai T, Kao CY, Chou CL, et al. (2016). Protective effect of magnolol-loaded polyketal microparticles on lipopolysaccharide-induced acute lung injury in rats. J Microencapsul 33:401–11.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Minayian M, Yazdekhasti S. (2017). Physicochemical, pharmacodynamic and pharmacokinetic characterization of soluplus stabilized nanosuspension of tacrolimus. Curr Drug Deliv 14:521–35.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhang C, Zheng Y, et al. (2010). The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine 6:170–8.
   PubMed Web of Science ®Google Scholar
• Yano K, Otsuka K, Kato Y, et al. (2016). Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins. J Pharm Pharmacol 68:361–7.
   PubMed Web of Science ®Google Scholar
• Ye L, Miao M, Li S, Hao K. (2017). Nanosuspensions of a new compound, ER-β005, for enhanced oral bioavailability and improved analgesic efficacy. Int J Pharm 531:246–56.
   PubMed Web of Science ®Google Scholar
• Yun Y, Cho YW, Park K. (2013). Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev 65:822–32.
   PubMed Web of Science ®Google Scholar
• Zeng YC, Sha LI, Liu C, et al. (2017). Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo. Acta Pharmacol Sin 38:424–33.
   PubMed Web of Science ®Google Scholar
• Zhang FH, Ren HY, Shen JX, et al. (2017a). Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway. Biomed Pharmacother 94:474–80.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang X, Zhao L, et al. (2015a). In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery. Drug Deliv 23:1–7.
   Web of Science ®Google Scholar
• Zhang J, Lv H, Jiang K, Gao Y. (2011). Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm 420:180–8.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang G, See E, et al. (2015b). Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation. J Control Release 203:161–9.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen Y, Deng J, et al. (2014). Solid dispersion of berberine–phospholipid complex/TPGS 1000/SiO2: preparation, characterization and in vivo studies. Int J Pharm 465:306–16.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cui C, Wei F, Lv H. (2017b). Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system. Drug Dev Ind Pharm 43:1276–82.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lv H, Jia X, et al. (2012). Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II. Pharmazie 67:59–62.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Wang XP, Ayman WY, et al. (2013). Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv 20:86–93.
   PubMed Web of Science ®Google Scholar
• Zhao C, Liu ZQ. (2011). Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA. Biochimie 93:1755–60.
   PubMed Web of Science ®Google Scholar
• Zong L, Li X, Wang H, et al. (2017). Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(β-Benzyl-l-aspartate) (PEG-PBLA). Int J Pharm 531:108–17.
   PubMed Web of Science ®Google Scholar